+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Discovery Technologies

  • ID: 5310246
  • Report
  • March 2021
  • Region: Global
  • 193 Pages
  • BCC Research

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • Biomax Informatics Ag
  • Codex Biosolutions Inc.
  • Illumina, Inc.
  • Multispan Inc.
  • Qiagen N.V.

In recent years, the drug discovery technologies industry has seen remarkable developments and rapid progress. This report focuses on the global drug discovery technologies market and provides an updated review to include basic design and its applications in different disease areas. The drug discovery technologies include high-throughput screening, bioanalytical instruments, cell-based assays and reagents, genomics, bioinformatics, proteomics, and few others, like combinatorial chemistry, metabolomics, nanotechnology and system biology. These technologies are further classified into subcategories for the purpose of this report. The five main disease application areas described in this report concern different cancer diseases, immunological diseases, neurological diseases, cardiovascular diseases and others, including metabolic, endocrinology and genetic diseases. The report also covers the market by end-user for drug discovery technologies, segmented into biopharmaceutical companies, research and academia, and contract research organizations (CROs).

This report is global in scope and includes an analysis of the various regulatory environments, advancements, new products, market projections and market shares. Also, the report includes relevant patent analysis and comprehensive profiles of companies that lead the drug discovery technologies market. The geographical regions covered are North America, Europe, Asia-Pacific and the Rest of the World. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data is provided for 2019 as the base year, 2020, and forecast through year-end 2025. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

The report includes:

  • 31 data tables and 16 additional tables
  • An overview of the global market for drug discovery technologies
  • Estimation of the market size and analyses of global market trends, with data from 2019, 2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Evaluation of market forecast, pipeline analysis of new products, regulatory scenarios and detailed analysis of drivers, challenges, and opportunities affecting the market growth
  • Market share analysis of drug discovery technologies based on type, application, end-user, and region
  • Information on reverse transcription-polymerase chain reaction (qRT-PCR), and next-generation sequencing (NGS) and coverage of bioanalytical instruments used for drug discovery
  • Information on pharmacokinetics and pharmacodynamics, and classification of techniques used in drug discovery
  • Discussion on bioinformatics as a platform for drug discovery and comparison between proteomics and genomics drug discovery technology
  • Detailed description of COVID-19 including symptoms and progression, its effect on medical tourism and insurance providers and coverage of government expenditure on COVID-19
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Comprehensive company profiles of major players of the industry, including Thermo Fisher Scientific, General Electric Co., Agilent, Illumina, Merck KGaA and Bio-Rad Laboratories
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • Biomax Informatics Ag
  • Codex Biosolutions Inc.
  • Illumina, Inc.
  • Multispan Inc.
  • Qiagen N.V.

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst’s Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights

  • Market Highlights: Drug Discovery Technologies

Chapter 3 Impact of COVID-19 Pandemic

  • Introduction
  • Outbreak
  • Symptoms of COVID-19
  • Progression of COVID-19
  • Spread of Disease
  • Impact on Medical Device Market
  • Elective and Noncritical Procedures
  • Shift in Manufacturing
  • Regulatory Delays, Clinical Trials and Product Launches
  • Supply Chain Disruptions
  • Medical Tourism
  • Impact of COVID-19 on Pharma Supply Chain
  • Impact of COVID-19 on the Global Economy
  • Government Expenditure on COVID-19
  • Impact on Insurance Providers
  • Impact of COVID-19 on Drug Discovery Technologies Industry
  • Clinical Trials on Hold
  • New Reality for Ongoing Studies
  • Ensuring Access to Study Drugs

Chapter 4 Market and Technology Background

  • Some Related Terms
  • Toxicity
  • Metabolism
  • Analytical Chemistry
  • Pharmacokinetics
  • Pharmacodynamics
  • Introduction
  • Process of Drug Discovery
  • History of Drug Discovery
  • Classification of Techniques Used in Drug Discovery
  • High-throughput Screening
  • Bioanalytical Instruments for Drug Discovery
  • Cell-based Assays and Reagents for Drug Discovery
  • Proteomics Drug Discovery Technologies
  • Genomics Drug Discovery Technologies
  • Bioinformatics as Platform for Drug Discovery
  • Others: Metabolomics-based Technologies, Combinatorial Chemistry, Systems Biology, Nanotechnology

Chapter 5 Market Breakdown by Technology Type

  • Global Market for Drug Discovery Technologies, by Type
  • High-Throughput Screening (HTS)
  • Market Size and Forecast
  • Market Analysis
  • Bioanalytical Instruments for Drug Discovery
  • Market Size and Forecast
  • Market Analysis
  • Cell-Based Assays and Reagents for Drug Discovery
  • Market Size and Forecast
  • Market Analysis
  • Proteomics Drug Discovery
  • Market Size and Forecast
  • Market Analysis
  • Genomics Drug Discovery
  • Market Size and Forecast
  • Market Analysis
  • Bioinformatics as Platform for Drug Discovery
  • Market Size and Forecast
  • Market Analysis
  • Others Drug Discovery Technologies
  • Market Size and Forecast
  • Market Analysis

Chapter 6 Market Breakdown by Disease Application

  • Global Market for Drug Discovery Technologies, by Disease Application
  • Cancer Diseases
  • Market Size and Forecast
  • Market Analysis
  • Cardiovascular Diseases
  • Market Size and Forecast
  • Market Analysis
  • Immunological Diseases
  • Market Size and Forecast
  • Market Analysis
  • Neurological Diseases
  • Market Size and Forecast
  • Market Analysis
  • Others
  • Market Size and Forecast
  • Market Analysis

Chapter 7 Market Breakdown by End-user

  • Global Market for Drug Discovery Technologies, by End-user
  • Biopharmaceutical Companies
  • Market Size and Forecast
  • Market Analysis
  • Research and Academia
  • Market Size and Forecast
  • Market Analysis
  • Contract Research Organizations (CROs)
  • Market Size and Forecast
  • Market Analysis

Chapter 8 Market Breakdown, by Region

  • Global Market for Drug Discovery Technologies, by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 9 Industry Structure

  • High-Throughput Screening
  • Bioanalytical Instruments
  • Cell-Based Assays and Reagents
  • Proteomics
  • Genomics
  • Bioinformatics
  • Other Drug Discovery Technologies

Chapter 10 Patent Review/New Developments/Regulatory Aspects

  • Patent Review
  • Patents by Year
  • Patents by Type
  • Patents by Company
  • Patents by Country
  • Patents by Assignee
  • Products and Developments
  • Mergers and Acquisitions
  • Awards for Drug Discovery Technologies
  • Regulatory Aspects

Chapter 11 Analysis of Market Opportunities

  • Factors Affecting the Drug Discovery Technologies Market
  • Drivers of the Drug Discovery Technologies Market
  • Current Challenges for the Drug Discovery Technologies Market

Chapter 12 Company Profiles

  • Agilent Technologies Inc.
  • Ametek Inc.
  • Arrayit Corp.
  • Beckton, Dickinson And Co. (Bd Biosciences)
  • Biomax Informatics Ag
  • Bio-Rad Laboratories
  • Bruker Corp.
  • Charles River Laboratories International, Inc.
  • Codex Biosolutions Inc.
  • Danaher Corp.
  • General Electric Co.
  • Hitachi High-Technologies Corp.
  • Illumina, Inc.
  • Integrated Dna Technologies, Inc.
  • Jeol Usa, Inc.
  • Leco Corp.
  • Merck Kgaa (Emd Millipore)
  • Multispan Inc.
  • Perkinelmer Inc.
  • Promega Corp.
  • Qiagen N.V.
  • Roche Holding Ltd.
  • Shimadzu Corp.
  • Thermo Fisher Scientific

Chapter 13 Appendix: List of Acronyms

List of Tables
Summary Table: Global Market for Drug Discovery Technologies, by Type, Through 2025
Table 1: Distribution of COVID-19 Clinical Symptoms
Table 2: Expenditures on COVID-19 Crisis, by Selected Country
Table 3: Interim Economic Outlook Forecasts, by Country/Region, 2019-2021
Table 4: History of Drug Discovery
Table 5: Cell Biology Reagents and Their Functions
Table 6: Protein Microarrays and Their Functions
Table 7: Differences Between Solid-Phase and Solution-Phase Synthesis
Table 8: Global Market for Drug Discovery Technologies, by Type, Through 2025
Table 9: Global Market for Bioanalytical Instruments and Technology, by Type, Through 2025
Table 10: Global Market for Cell-Based Assays and Reagents, by Type, Through 2025
Table 11: Global Market for Proteomics Drug Discovery Technology, by Type, Through 2025
Table 12: Global Market for Genomic Drug Discovery Technology, by Type, Through 2025
Table 13: Global Market for Drug Discovery Technologies, by Disease Application, Through 2025
Table 14: Global Market for Drug Discovery Technologies, by End-User, Through 2025
Table 15: Global Market for Drug Discovery Technologies, by Region, Through 2025
Table 16: North American Market for Drug Discovery Technologies, by Country, Through 2025
Table 17: North American Market for Drug Discovery Technologies, by Type, Through 2025
Table 18: North American Market for Drug Discovery Technologies, by Disease Application, Through 2025
Table 19: North American Market for Drug Discovery Technologies, by End-User, Through 2025
Table 20: European Market for Drug Discovery Technologies, by Country, Through 2025
Table 21: European Market for Drug Discovery Technologies, by Type, Through 2025
Table 22: European Market for Drug Discovery Technologies, by Disease Application, Through 2025
Table 23: European Market for Drug Discovery Technologies, by End-User, Through 2025
Table 24: Asia-Pacific Market for Drug Discovery Technologies, by Country, Through 2025
Table 25: Asia-Pacific Market for Drug Discovery Technologies, by Type, Through 2025
Table 26: Asia-Pacific Market for Drug Discovery Technologies, by Disease Application, Through 2025
Table 27: Asia-Pacific Market for Drug Discovery Technologies, by End-User, Through 2025
Table 28: Rest of the World Market for Drug Discovery Technologies, by Type, Through 2025
Table 29: Rest of the World Market for Drug Discovery Technologies, by Disease Application, Through 2025
Table 30: Rest of the World Market for Drug Discovery Technologies, by End-User, Through 2025
Table 31: Manufacturers/Suppliers of High-Throughput Screening Technology
Table 32: Manufacturers/Suppliers of Bioanalytical Instruments
Table 33: Manufacturers/Suppliers of Cell-Based Assays and Reagents
Table 34: Manufacturers/Suppliers of Proteomics Technology
Table 35: Manufacturers/Suppliers of Genomics Technology
Table 36: Manufacturers/Suppliers of Bioinformatics Technology
Table 37: Manufacturers/Suppliers of Other Drug Discovery Technologies
Table 38: Patents Issued for Drug Discovery Technologies, by Year, January 2016-June 2017
Table 39: Patents Issued for Drug Discovery Technologies, by Type, January 2016-June 2017
Table 40: Patents Issued for Drug Discovery Technologies, by Company, January 2016- June 2017
Table 41: Patents Issued for Drug Discovery Technologies, by Country, January 2016- June 2017
Table 42: Patents Issued for Drug Discovery Technologies, by Assignee, January 2016- June 2017
Table 43: Developments for Drug Discovery Technologies
Table 44: Mergers and Acquisitions of Drug Discovery Technologies Companies
Table 45: Awards for Drug Discovery Technologies Products
Table 46: Acronyms Used in the Drug Discovery Technologies Industry

List of Figures
Summary Figure A: Global Market for Drug Discovery Technologies, by Type, 2019-2025
Summary Figure B: Global Market Shares of Drug Discovery Technologies, by Type, 2020
Figure 1: Comparison of GDP Growth, by Country, 2019 and 2020
Figure 2: Process of Drug Discovery
Figure 3: Global Market Shares of Drug Discovery Technologies, by Type, 2020
Figure 4: Global Market for High-Throughput Screening, 2019-2025
Figure 5: Global Market for Bioanalytical Instruments for Drug Discovery, 2019-2025
Figure 6: Global Market for Cell-Based Assays and Reagents for Drug Discovery, 2019-2025
Figure 7: Global Market for Proteomics Drug Discovery, 2019-2025
Figure 8: Global Market for Genomics Drug Discovery, 2019-2025
Figure 9: Global Market for Bioinformatics as Platform for Drug Discovery, 2019-2025
Figure 10: Global Market for Others Drug Discovery Technologies, 2019-2025
Figure 11: Global Market Shares of Drug Discovery Technologies, by Disease Application, 2020
Figure 12: Global Market for Drug Discovery Technologies for Cancer Diseases, 2019-2025
Figure 13: Global Market for Drug Discovery Technologies for Cardiovascular Diseases, 2019-2025
Figure 14: Global Disease Burden, 2017
Figure 15: Global Market for Drug Discovery Technologies for Immunological Diseases, 2019-2025
Figure 16: Global Market for Drug Discovery Technologies for Neurological Diseases, 2019-2025
Figure 17: Global Market for Drug Discovery Technologies for Other Diseases, 2019-2025
Figure 18: Global Market Shares of Drug Discovery Technologies, by End-User, 2020
Figure 19: Global Market for Drug Discovery Technologies for Biopharmaceutical Companies, 2019-2025
Figure 20: Global Market for Drug Discovery Technologies for Research and Academia, 2019-2025
Figure 21: Global Market for Drug Discovery Technologies for Contract Research Organizations, 2019-2025
Figure 22: Global Market Shares of Drug Discovery Technologies, by Region, 2020
Figure 23: North American Market for Drug Discovery Technologies, 2019-2025
Figure 24: North American Market Shares of Drug Discovery Technologies, by Country, 2020
Figure 25: North American Market Shares of Drug Discovery Technologies, by Type, 2020
Figure 26: North American Market Shares of Drug Discovery Technologies, by Disease Application, 2020
Figure 27: North American Market Shares of Drug Discovery Technologies, by End-User, 2020
Figure 28: European Market for Drug Discovery Technologies, 2019-2025
Figure 29: European Market Shares of Drug Discovery Technologies, by Country, 2020
Figure 30: European Market Shares of Drug Discovery Technologies, by Type, 2020
Figure 31: European Market Shares of Drug Discovery Technologies, by Disease Application, 2020
Figure 32: European Market Shares of Drug Discovery Technologies, by End-User, 2020
Figure 33: Asia-Pacific Market for Drug Discovery Technologies, 2019-2025
Figure 34: Asia-Pacific Market Shares of Drug Discovery Technologies, by Country, 2020
Figure 35: Asia-Pacific Market Shares of Drug Discovery Technologies, by Type, 2020
Figure 36: Asia-Pacific Market Shares of Drug Discovery Technologies, by Disease Application, 2020
Figure 37: Asia-Pacific Market Shares of Drug Discovery Technologies, by End-User, 2020
Figure 38: Rest of the World Market for Drug Discovery Technologies, 2019-2025
Figure 39: Rest of the World Market Shares of Drug Discovery Technologies, by Type, 2020
Figure 40: Rest of the World Market Shares of Drug Discovery Technologies, by Disease Application, 2020
Figure 41: Rest of the World Market Shares of Drug Discovery Technologies, by End-User, 2020
Figure 42: Patents Issued for Drug Discovery Technologies, by Year, January 2016-June 2017
Figure 43: Patents Issued for Drug Discovery Technologies, by Type, January 2016-June 2017
Figure 44: Patents Issued for Drug Discovery Technologies, by Assignee, January 2016- June 2017
Figure 45: Steps from Drug Discovery to Regulatory Approval
Figure 46: Agilent: Annual Revenue, 2018-2020
Figure 47: Agilent: Revenue Share, by Region, 2020
Figure 48: Agilent: Revenue Share, by Segment, 2020
Figure 49: Ametek: Annual Revenue, 2017-2019
Figure 50: Ametek: Revenue Share, by Segment, 2019
Figure 51: Bio-Rad Laboratories: Annual Revenue, 2017-2019
Figure 52: Bio-Rad Laboratories: Revenue Share, by Region, 2019
Figure 53: Bio-Rad Laboratories: Revenue Share, by Segment, 2019
Figure 54: Bruker Corp.: Annual Revenue, 2018 and 2019
Figure 55: Bruker: Revenue Share, by Region, 2019
Figure 56: Bruker Corp.: Revenue Share, by Segment, 2019
Figure 57: Charles River Laboratories International Inc.: Annual Revenue, 2018-2020
Figure 58: Charles River Laboratories International Inc.: Revenue Share, by Segment, 2020
Figure 59: Danaher Corp.: Annual Revenue, 2017-2019
Figure 60: Danaher Corp.: Revenue Share, by Region/Economies, 2019
Figure 61: Danaher Corp.: Revenue Share, by Segment, 2019
Figure 62: General Electric Co.: Annual Revenue, 2019-2020
Figure 63: General Electric Co.: Revenue Share, by Segment, 2020
Figure 64: Hitachi High-Technologies: Annual Revenue, 2018 and 2019
Figure 65: Illumina: Annual Revenue, 2018-2020
Figure 66: Illumina: Revenue Share, by Region, 2020
Figure 67: Illumina: Revenue Share, by Segment, 2020
Figure 68: Merck KGaA: Annual Revenue, 2018-2019
Figure 69: Merck KGaA: Revenue Share, by Region, 2019
Figure 70: Merck KGaA: Revenue Share, by Business Sector, 2019
Figure 71: PerkinElmer: Annual Revenue, 2017-2019
Figure 72: PerkinElmer: Revenue Share, by Region, 2019
Figure 73: Qiagen: Annual Revenue, 2017-2019
Figure 74: Qiagen: Revenue Share, by Region, 2019
Figure 75: Qiagen: Revenue Share, by Segment, 2019
Figure 76: Thermo Fisher Scientific: Annual Revenue, 2017-2019
Figure 77: Thermo Fisher Scientific: Revenue Share, by Segment, 2019

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • Biomax Informatics Ag
  • Codex Biosolutions Inc.
  • Illumina, Inc.
  • Multispan Inc.
  • Qiagen N.V.

The drug discovery industry witnessed growth in the past several years owing to progress in biochemical, translational and molecular studies in biomedical research. These technologies are commercially employed in the development of new and efficient drug candidates. The booming healthcare sector and increased government funding have aided notable growth in this market. The delineation of mechanistic details and the underlying mechanisms of drug-target interaction have paved the way for more accurate and effective therapies.

The growing field of drug discovery and development is enabling researchers to focus on discovering essential lead compounds for different forms of cancer and other diseases. Biopharmaceutical companies and various research institutes are conducting research in the field of drug discovery technologies. Globally, research institutes and biopharmaceutical companies are exploring several molecular and biochemical aspects to develop mechanistic approaches for drug discovery. Various technologies, such as high-throughput screening, proteomics and genomics, including quantitative reverse transcription-polymerase chain reaction (qRT-PCR), next-generation sequencing (NGS) and many others, are being widely used for cellular analysis.

A rise in R&D, increasing incidences of various life-threatening diseases, and the increasing global population are all market drivers. The companies in this industry are focusing on enhancing biomedical research and the advancement of superior technologies in order to provide better quality treatments and therapies.

Collaborative efforts of researchers and the pharmaceutical industry are establishing various promising future drug candidates. Drug discoveries find applications in cardiovascular, neurological, cancer and other disease areas. However, the rapid spread of COVID-19 has thrown countless businesses into a frenzy. The healthcare industry, in particular, is facing growing pressure to rapidly-produce tests needed in nearly every region around the world.

The virus has created unprecedented challenges for the healthcare industry. COVID-19 has put the healthcare industry at center stage with the remarkable demand for diagnostic tests, personal protective equipment (PPE), ventilators and other critical medical supplies. Moreover, for the unusual measures underway to rapidly ramp up manufacturing capacity and capabilities, healthcare leaders are also looking outside their normal sector boundaries to explore creative solutions to supplement further capacity, like partnerships with companies outside the sector, open-source equipment design and deployment of medically trained employees to support public-health needs.

Note: Product cover images may vary from those shown
  • Agilent Technologies Inc.
  • Ametek Inc.
  • Arrayit Corp.
  • Beckton, Dickinson And Co. (Bd Biosciences)
  • Biomax Informatics Ag
  • Bio-Rad Laboratories
  • Bruker Corp.
  • Charles River Laboratories International, Inc.
  • Codex Biosolutions Inc.
  • Danaher Corp.
  • General Electric Co.
  • Hitachi High-Technologies Corp.
  • Illumina, Inc.
  • Integrated Dna Technologies, Inc.
  • Jeol Usa, Inc.
  • Leco Corp.
  • Merck Kgaa (Emd Millipore)
  • Multispan Inc.
  • Perkinelmer Inc.
  • Promega Corp.
  • Qiagen N.V.
  • Roche Holding Ltd.
  • Shimadzu Corp.
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
Adroll
adroll